Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts

Introduction Improvement in the ability to target underlying drivers and vulnerabilities of high-grade serous ovarian cancer (HG-SOC) requires the development of molecularly annotated pre-clinical models reflective of clinical responses.